Indication

Haemophilus parainfluenza pneumonia

Haemophilus parainfluenza pneumonia is a lower respiratory tract infection of the pulmonary parenchyma caused by *Haemophilus parainfluenzae*, a fastidious, pleomorphic Gram-negative coccobacillus that commonly colonizes the human oropharynx as a commensal. Read more about Haemophilus parainfluenza pneumonia

202 drugs 102 manufacturers

Advertisement

Drugs that treat it

Common Haemophilus parainfluenza pneumonia therapies.

Showing 10–18 of 202 drugs

Filter & compare in the drug finder →Opens the drug finder with Haemophilus parainfluenza pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Haemophilus parainfluenza pneumonia.

Haemophilus parainfluenza pneumonia is a lower respiratory tract infection of the pulmonary parenchyma caused by *Haemophilus parainfluenzae*, a fastidious, pleomorphic Gram-negative coccobacillus that commonly colonizes the human oropharynx as a commensal.

While it can occasionally cause community-acquired pneumonia in immunocompetent individuals, it primarily functions as an opportunistic pathogen in older adults, immunocompromised patients, or individuals with chronic underlying pulmonary disorders.

Pathophysiologically, microaspiration of colonizing flora into the lower respiratory tract triggers alveolar inflammation and pulmonary consolidation.

Defining clinical features typically include fever, productive cough with purulent sputum, dyspnea, pleuritic chest discomfort, and focal lung infiltrates demonstrable on chest imaging.

Personalize your experience

Follow Haemophilus parainfluenza pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it